Hyeong‐Seok Lim

Comprehensive Analysis of<i>UGT1A</i>Polymorphisms Predictive for Pharmacokinetics and Treatment Outcome in Patients With Non–Small-Cell Lung Cancer Treated With Irinotecan and Cisplatin

Ji‐Youn Han, Hyeong‐Seok Lim, Eun‐Soon Shin et al. · Journal of Clinical Oncology · 2006 · 298 citations · Full text

Medicine, Oncology, Pharmacology +16

Clinical Implications of CYP2D6 Genotypes Predictive of Tamoxifen Pharmacokinetics in Metastatic Breast Cancer

Hyeong‐Seok Lim, Han Ju Lee, Keun Seok Lee et al. · Journal of Clinical Oncology · 2007 · 268 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Associations of <i>ABCB1, ABCC2</i>, and <i>ABCG2</i> polymorphisms with irinotecan‐pharmacokinetics and clinical outcome in patients with advanced non‐small cell lung cancer

Ji‐Youn Han, Hyeong‐Seok Lim, Yeon‐Kyeong Yoo et al. · Cancer · 2007 · 197 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16

Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by<i>Plasmodium vivax</i>

Hyeong‐Seok Lim, Jeong-Soo Im, Joo‐Youn Cho et al. · Antimicrobial Agents and Chemotherapy · 2009 · 168 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer

Ji‐Youn Han, Hyeong‐Seok Lim, Yong Hoon Park et al. · Lung Cancer · 2008 · 104 citations

Medicine, Pharmacokinetics, Pharmacology +16